Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

161 results about "High homology" patented technology

Nucleic acid aptamer and screening method thereof, and application of nucleic acid aptamer in prostate cancer cell strain detection

The present invention discloses a nucleic acid aptamer, wherein the sequence of the nucleic acid aptamer comprises a DNA segment represented by any one sequence selected from a sequence 1, a sequence 2 and a sequence 3. The nucleic acid aptamer can further be various similar sequences with high homology or a derivative obtained from the sequence of the present invention. The invention further discloses a nucleic acid aptamer screening method, which comprises: synthesizing a random single-stranded DNA library and primers, carrying out SELEX screening, carrying out PCR amplification of library, preparing a DNA single strand library, and finally carrying out repeated screening, negative screening and multi-round screening to obtain the nucleic acid aptamer. The nucleic acid aptamer and the derivative thereof can be used in recognition of the prostate cancer cell strain PC-3 or preparation of kits, molecular probes and targeted mediums for prostate cancer detection, and can further be used in design and preparation of prostate cancer treatment drugs. Compared with the protein antibody, the nucleic acid aptamer of the present invention has advantages of high affinity, high specificity, no immunogenicity, capability of being chemically synthesized, small molecular weight, stability, easy storage, easy labeling and the like.
Owner:GUANGZHOU SHIWEN BIOTECHNOLOGY CO LTD

LncRNA and application thereof as detection marker or prognosis recurrence marker for breast cancer combined with lung cancer

The invention discloses lncRNA and application thereof as a detection marker or a prognosis recurrence marker for breast cancer combined with lung cancer. The lncRNA is at least one of the following nucleic acid molecules: (1) nucleic acid molecules with cDNA sequences as shown in SEQ ID NO.1, SEQ ID NO.2 or SEQ ID NO.3; and (2) nucleic acid molecules with 90% and higher homology with the nucleic acid molecules with the cDNA sequences as shown in the SEQ ID NO.1, SEQ ID NO.2 or SEQ ID NO.3. According to the lncRNA and application thereof, a group of lncRNAs are screened out as the molecular markers for the breast cancer combined with lung cancer, associated primers are optimized for preparing primer probe chips, and the lncRNA has the advantages of low detection cost, high sensitivity and the like; and the lncRNA and application thereof take the breast cancer combined with lung cancer, such combined cancer, as an example, and take the lead in filling up the blank in research of the combined biological marker lncRNA in China. The lncRNA and application thereof adopt a group of lncRNAs as associated biological markers for combined cancer, and can effectively improve the clinical diagnosis and prognosis evaluation of the combined cancer for instructing clinical treatment.
Owner:ZHEJIANG SCI-TECH UNIV

Novel fructosyl peptide oxidase

ActiveUS20120003678A1Strong specificityStable fructosyl peptide oxidase activityFungiBacteriaEscherichia coliHigh homology
A protein described in any one of [1] to [4] below is provided according to the present invention:[1] a protein comprising the amino acid sequence represented by SEQ ID NO: 1;[2] a protein comprising an amino acid sequence with one or more amino acid deletions, substitutions, or additions in the amino acid sequence represented by SEQ ID NO: 1, and having fructosyl peptide oxidase activity;[3] a protein comprising an amino acid sequence having 80% or higher homology to the amino acid sequence represented by SEQ ID NO: 1, and having fructosyl peptide oxidase activity; and[4] a protein having fructosyl peptide oxidase activity, which is produced by an expression plasmid harbored by the Escherichia coli XL1-Blue MRF' strain deposited under Accession No. FERM BP-11026.
Owner:KYOWA MEDEX CO LTD

Homology retrieval system, homology retrieval apparatus, and homology retrieval method

A homology retrieval can be performed with higher accuracy than conventional technologies when comparing a query sequence with a target sequence, and retrieving a similar location in the target sequence. The sequence information of a query sequence and a genomic-scale target sequence is acquired, the acquired information is compressingly converted into a compressed query sequence and a compressed target sequence in each of which a homopolymer region including two or more consecutive identical bases is replaced with a single base of the bases, the two sequences are compared, and a refining search is performed for a compressed target partial sequence that matches the compressed query sequence in the compressed target sequence. For the refined compressed candidate sequence and the query sequence, based on the information on the number of consecutive identical bases in the each of the sequences before compression, the number of consecutive bases is compared between the two compressed sequences for each corresponding base, and the degree of similarity indicating homology of the candidate sequence with the query sequence is computed from a degree of match or a degree of mismatch in the number of consecutive bases. By ranking and selecting an arbitrary number of candidate sequences having relatively high homology with the query sequence from this degree of similarity, it is possible to avoid the influence of the number of consecutive identical bases in a homopolymer region, thereby performing a homology retrieval accurately.
Owner:INTER UNIV RES INST RES ORG OF INFORMATION & SYST

Maize gene ZmGRAS37 for regulating and controlling nutrient body largeness, early blossoming and grain weight increment of arabidopsis thaliana at seedling stage and application thereof

The invention provides a maize gene ZmGRAS37 for regulating and controlling the nutrient body largeness, the early blossoming and the grain weight increment of arabidopsis thaliana at a seedling stage and application thereof. According to the maize gene ZmGRAS37, the gene ZmGRAS37 is separated and cloned from maize; the cDNA (complementary Deoxyribonucleic Acid) sequence of the ZmGRAS37 is connected to an expression vector pPZP211 promoted by a 35S promoter; the arabidopsis thaliana is infected and converted by utilizing an agrobacterium infection method; indicated by an experimental result, the gene can be used for enabling the model-plant arabidopsis thaliana to generate characters of the nutrient body largeness and to further have the early blossoming, the grain weight increment and the like at the seedling stage. Shown by a phylogenetic-tree analysis result, the direct homologous gene of the gene does not exist in the model-plant arabidopsis thaliana; however, the gene has the higher homology with that of sorghum and maize of gramineous plants; the gene is accounted to be the peculiar GRAS (Generally Recognized as Safe) family gene of the graminaceous plants; in consideration of the conservatism of the gene in the graminaceous plants and the phenotypes presented in transgenic arabidopsis thaliana, the gene is proven to have potential application value.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

Method for cloning rice auxin induced protein gene

The invention relates to a method for using rice auxin to induce protein genes to be cloned, which is characterized in that the implementation steps comprise: (1) the preparation of a rice transformation receptor; (2) the genetic transformation of the rice; (3) the screening of kanamycin-resistant callus tissue and the regeneration of plants; (4) the screening of the mutant of a T-DNA inserted progenies; (5) Tail-PCR; (6) the comparison and analysis of sequences on the Internet. In the invention, a rice mutant with a short plant height is obtained when carrying out rice functional genome research by using T-DNA label method; the lateral neighboring sequences of the mutant are researched by using TAIL-PCR technology; meanwhile, the position where the mutant T-DNA inserts the rice genome is arranged on the No. 4 chromosome of the rice by the comparison on the databases of NCBI and TIGR on the Internet; moreover, the rice BAC clone (OSJNBa0084K01) of the position is found out. The T-DNA is inserted between the two genes of the clone by analyzing the clone. Known functional genes with a very high homology with BAC cloning code amino acid sequence are forecasted by the sequence comparison on the Internet.
Owner:TIANJIN AGRICULTURE COLLEGE

Hydrazine cathepsin K inhibitor and application thereof in treating osteoporosis

The invention provides a hydrazine cathepsin K inhibitor and an application of the inhibitor in treating osteoporosis, which belong to the technical field of cathepsin inhibitors. The inhibitor does not include a P2-P3 connection part but have different P3 locus structures. The structure is represented by the following formula, and in the formula, P3 is aryl and comprises para-biphenyl, para-phenyl-pyridine, para-phenyl thiophene, para-terphenyl and meta-terphenyl. The non-peptide hydrazine cathepsin inhibitor designed and synthesized in the invention has the advantages of being relatively simple in structure, easy to get in materials, convenient to synthesize and high in yield; the design and the synthesis of the matrix structure greatly facilitate the synthesis of subsequent final products. By adopting the inhibitor, the inhibiting effect to the cathepsin K is higher than sub-nano-mole level, and the inhibiting effect to B and S is on micro-mole level, and the difference of inhibiting effects of cathepsin K and cathepsin L with extremely high homology is increased, thus the possibility of developing the inhibitor as the medicine for treating osteoporosis is increased.
Owner:JILIN UNIV

Functional humanization of complementarity determining regions (CDRS)

Current humanization approaches for immunoglobulins focus mostly on modifying the framework regions into human sequences. Herein is provided a method for humanizing antibody complementarity-determining regions (CDRs) through functional humanization to reduce the potential immunogenicity of non-human CDR-containing antibodies. CDRs with high sequence homology to the parent CDR are identified from a database of human CDR sequences. One or more human CDRs that are highly homologous to the parent CDR sequence can be used to replace the corresponding CDRs of murine immunoglobulins (or their humanized, or re-engineered versions). Human CDRs that improve or have minimal effects on the antigen binding affinity and specificity are adopted.
Owner:SINOMAB BIOSCI

Cabbage type rape, parent species Chinese cabbage thereof, cabbage TT2 (Transparent Testa 2) gene family and application thereof

The invention relates to the technical field of gene engineering, in particular to cabbage type rape, a parent species Chinese cabbage thereof, a cabbage TT2 (Transparent Testa 2) gene family and application thereof. The Chinese cabbage TT2 gene family comprises two members of a BrTT2-1 gene and a BrTT2-2 gene; the cabbage TT2 gene family has one member of a BoTT2 gene; the cabbage type rape TT2 gene family comprises three members of a BnTT2-1 gene, a BnTT2-2 gene and a BnTT2-3 gene; and the six brassica TT2 genes have higher homology. The invention also discloses the application of the gene family in plant molecular breeding. After the antisense inhibition of the expression of the cabbage type rape in black-seed cabbage type rape, a transgenic plant generates the character variation of testa color lightening, and the like and has potential for creating transgenic yellow-seed materials.
Owner:SOUTHWEST UNIVERSITY

Preparation method for B cell CD 22 extracellular inhibitive peptide fragment B2285 vaccines

The invention provides a preparation method for B cell CD 22 extracellular peptide fragment B2285 vaccines. Sequential eight amino acids from the 85th to the 93rd starting at an amino terminal in a mice CD 22 molecule amino acid sequence, specifically in a sequence of Lys- Thr- Glu- Lys- Asp-Pro- Glu- Ser- Glu, are selected. The sequence is similar to the sequence of Lys- Asp- Gly- Lys- Val- Pro-Ser- Glu, having the sequential eight amino acids from the 81st to the 88th starting at the amino terminal in a human CD 22 molecular amino acid sequence, is located at the same functional region in a spatial structure, and has high homology. A prepared vaccine or a drug composite containing B2285 has the functions of inhibiting B cell proliferation, activating and generating antibody per se, canbe applicable to treating immunologic diseases involved or mediated B cells such as dilated cardiomyopathy testing positive in an anti-myocardial antibody, systemic lupus erythematosus with a positive antibody per se, and the like.
Owner:XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products